Clene Inc. Common Stock

CLNNNASDAQUSD
5.28 USD
0.08 (1.64%)🟢PRE MARKET (AS OF 07:35 PM EDT)
🟢Market: OPEN

Shares of Clene Inc. Common Stock (CLNN) are trading at $5.28. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (177.9%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 4, 2026.

Open?$5.33
High?$5.57
Low?$5.23
Prev. Close?$5.19
Volume?42.6K
Avg. Volume?62.5K
VWAP?$5.31
Rel. Volume?0.68x
Bid / Ask
Bid?$4.36 × 100
Ask?$6.10 × 100
Spread?$1.74
Midpoint?$5.23
Valuation & Ratios
Market Cap?67.5M
Shares Out?12.8M
Float?8.3M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-3.59
EPS?-$2.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Employees
79
Market Cap
66.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-12-31
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121
Phone: 801-676-9695
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
3
Short Sent.?
53
Piotroski F-Score?2/9Weak
Altman Z-Score?-22.32Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?11.18%High
Short Interest?925.4K
Days to Cover?18.4
Free Float8.3M
Avg Daily Volume50.2K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.94Adequate
Quick Ratio?1.93Adequate
Cash Ratio?0.88Adequate
Debt/Equity?-0.97Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-3.59CHEAP
P/S?
Peers
100
S&P
3
503.50HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.1CHEAP
EV/Sales?
Peers
100
S&P
3
595.04HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
177.9%STRONG
ROA?
S&P
3
-154.4%WEAK
Cash Flow & Enterprise
FCF?$-18102000
Enterprise Value?$79.7M
Fundamentals ratios updated end of day